Barot BS et al. |
Physicochemical and structural characterization of iron-sucrose formulations: a comparative study. |
2014 |
Pharm Dev Technol |
pmid:23701359
|
Onken JE et al. |
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. |
2014 |
Nephrol. Dial. Transplant. |
pmid:23963731
|
Shah RB et al. |
Pharmaceutical characterization and thermodynamic stability assessment of a colloidal iron drug product: iron sucrose. |
2014 |
Int J Pharm |
pmid:24440404
|
Tiwari P and Gupta KP |
Modulation of miR-203 and its regulators as a function of time during the development of 7, 12 dimethylbenz [a] anthracene induced mouse skin tumors in presence or absence of the antitumor agents. |
2014 |
Toxicol. Appl. Pharmacol. |
pmid:24792773
|
Elford P et al. |
Biodistribution and predictive hepatic gene expression of intravenous iron sucrose. |
2013 Nov-Dec |
J Pharmacol Toxicol Methods |
pmid:23624021
|
Soufras GD et al. |
Fatal anaphylactic reaction to iron sucrose in pregnancy: iron-induced Kounis syndrome? |
2013 Nov-Dec |
Indian J Pharmacol |
pmid:24347784
|
Mishra A et al. |
Fatal anaphylactic reaction to iron sucrose in pregnancy. |
2013 Jan-Feb |
Indian J Pharmacol |
pmid:23543624
|
Palmer K et al. |
Review of available intravenous iron preparations in hemodialysis. |
2013 Apr-Jun |
CANNT J |
pmid:24069699
|
Janus N et al. |
Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey. |
2013 |
Support Care Cancer |
pmid:23715817
|
Giger M and Achermann R |
[Iron substitution in outpatients in Switzerland: Increase of costs associated with intravenous administration]. |
2013 |
Z Evid Fortbild Qual Gesundhwes |
pmid:23916272
|